Research ArticleClinical Studies

Adolescents and Young Adults (AYAs) With Initially Localized and Metastatic Bone Sarcomas: A Retrospective Single Center Analysis of Side Effect Management

CHRISTOPH MINICHSDORFER, OSKAR STEINBRECHER, MARITA KÖLZ, MAXIMILIAN SCHMID, MARKUS RADERER, THOMAS BRODOWICZ and WOLFGANG LAMM
In Vivo January 2021, 35 (1) 385-391; DOI: https://doi.org/10.21873/invivo.12269

Article Figures & Data

Figures

  • Figure 1.
    Figure 1.

    Progression-free survival (PFS) in osteosarcoma (OSA) and Ewing sarcoma (ES). Median PFS for patients with OSA was not reached and median PFS for ES was 19.2 months (range=4.1-34.3).

  • Figure 2.
    Figure 2.

    Overall survival (OS) in osteosarcoma (OSA) and Ewing sarcoma (ES). Median OS for patients with OSA was 36.3 months (range=11.7-60.9 months) and median OS for patients with ES was 54.7 months (range=21.7-87.6).

Tables

  • Table I.
  • Table II.
  • Table III.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Adolescents and Young Adults (AYAs) With Initially Localized and Metastatic Bone Sarcomas: A Retrospective Single Center Analysis of Side Effect Management
CHRISTOPH MINICHSDORFER, OSKAR STEINBRECHER, MARITA KÖLZ, MAXIMILIAN SCHMID, MARKUS RADERER, THOMAS BRODOWICZ, WOLFGANG LAMM
In Vivo Jan 2021, 35 (1) 385-391; DOI: 10.21873/invivo.12269
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords